entity

ITE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ITE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

6Connections

30Hypotheses

0Analyses

6Outgoing

0Incoming

4Experiments

0Debates

No AI portrait yet

Wiki Pages (2)

Knowledge base pages for this entity

ALSENLITE: Senolytics for Alzheimer's Disease Trial

treatment · 1194 words

→

ALSENLITE: Senolytics Trial for AD (NCT04785300)

clinical · 829 words

→

Outgoing (6)

Target	Relation	Type	Str
AhR	activates	protein	0.92
Retinal Local Inflammation	downregulates	process	0.90
Retinal Ganglion Cell Apoptosis	protects_against	process	0.90
Retinal Local Inflammation	downregulates	process	0.85
Retinal Ischemia/Reperfusion Injury	treats	disease	0.85
ERK	inhibits	protein	0.85

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drive	0.801	alzheimers	Cell type vulnerability in Alzheimers Di
ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligo	0.779	alzheimers	Cell type vulnerability in Alzheimers Di
Oligodendrocyte Precursor Cell Senescence in White Matter Di	0.769	-	Senescent cell clearance as neurodegener
GBA1-Deficiency Disrupts Mitochondrial- Lysosomal Contact Si	0.747	neurodegeneration	-
Gamma entrainment suppresses hippocampal ERK1/2 hyperactivit	0.711	alzheimers	Gamma entrainment therapy to restore hip

Loss of AQP4 Polarization Impairs Glymphatic Perivascular In	0.690	neurodegeneration	What are the specific molecular mechanis
Time-Limited AQP4 Inhibition for Acute Cytotoxic Edema Follo	0.690	neurodegeneration	How can AQP4 be effectively targeted the
STMN2 Restoration as a Prerequisite for Axon Growth After TD	0.683	neurodegeneration	What molecular mechanisms enable functio
Metabolic Checkpoint Failure in NG2+ Oligodendrocyte Progeni	0.680	neurodegeneration	-
White Matter Oligodendrocyte Protection via CXCL10 Inhibitio	0.675	neurodegeneration	Gene expression changes in aging mouse b
Mitochondrial-Lysosomal Contact Site Engineering	0.668	neurodegeneration	Autophagy-lysosome pathway convergence a
White Matter Vulnerability Prevention via Oligodendrocyte Pr	0.667	neurodegeneration	Gene expression changes in aging mouse b
RNA Granule Nucleation Site Modulation	0.662	neurodegeneration	TDP-43 phase separation therapeutics for
Oligodendrocyte White Matter Vulnerability	0.651	neurodegeneration	Gene expression changes in aging mouse b
TREM2-Mediated Oligodendrocyte-Microglia Metabolic Coupling	0.649	neurodegeneration	Gene expression changes in aging mouse b
CLU-APOE-TREM2 Tripartite Axis as a Coordinate Therapeutic T	0.648	neurodegeneration	Does clusterin exacerbate or protect aga
White Matter Immune Checkpoint Restoration	0.644	neurodegeneration	Gene expression changes in aging mouse b
Cross-Cell Type Synaptic Rescue via Tripartite Synapse Resto	0.620	neurodegeneration	Cell type vulnerability in Alzheimer's D
Neurovascular Permeability Score (NVPS): Composite Plasma +	0.600	-	Blood-brain barrier permeability changes
TREM2-Mediated Oligodendrocyte-Microglia Cross-talk in White	0.600	neurodegeneration	Gene expression changes in aging mouse b
OPC differentiation blockade contributes to white matter deg	0.599	alzheimers	SEA-AD Single-Cell Analysis: Cell-Type V
Aryl Hydrocarbon Receptor (AhR) Activation by Microbiome Met	0.597	neuroinflammation	What molecular mechanisms determine whet
TREM2-Mediated Oligodendrocyte-Microglia Signaling in White	0.587	neurodegeneration	Gene expression changes in aging mouse b
Residual Vascular Amyloid Prevents Complete CSF p-tau217 Nor	0.585	-	Can CSF p-tau217 normalization serve as
Gut Bacterial Metabolite-AhR Dysregulation Converts SCFA-Def	0.580	neurodegeneration	How does gut microbiome dysbiosis contri
Limited Calcium Release Without Sufficient Cathepsin Efflux	0.580	neurodegeneration	How does controlled lysosomal membrane p
Multi-Biomarker Composite Index Surpassing Amyloid PET for T	0.579	neurodegeneration	Multi-modal Biomarker Panel Design for E
NAC + Ferrostatin-1 Combination for Peroxynitrite-Ferroptosi	0.530	neurodegeneration	Can ferroptosis inhibitors prevent BBB d
ER-mitochondria contact-site dysfunction in neurodegeneratio	0.530	neurodegeneration	Test
Microbial Metabolite-Mediated α-Synuclein Disaggregation	0.511	neurodegeneration	What are the mechanisms by which gut mic

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (4)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Model	Status	Est. Cost
SIRPα modulation in mouse models of Alzheimer's disease	validation	Alzheimer's disease	0.900	mouse models of Alzheimer's di	proposed	N/A
CXCL10 biomarker analysis for CPSP prediction	clinical	chronic postsurgical pain	0.900	human patients undergoing thor	proposed	N/A
Microglial SIRPα expression in human Alzheimer's disease tissue	exploratory	Alzheimer's disease	0.800	human brain tissue	proposed	N/A
E2F coordination of G2/M transcriptional program	exploratory		0.750	endocycling mammalian cells	proposed	N/A

Related Papers (17)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
METTL3/CXCL10 axis contributes to renal fibrosis by promoting the apoptosis of t [PMID:41138934]	Sun Y, Ren Z, Ge J, Zhang W, Shao F et a	Biochim Biophys Acta Mol Basis	2026
IL-25-ILC2-IL-13 axis improves traumatic brain injury by mediating CXCL-10-depen [PMID:41527095]	Peng M, Shu D, Chen Z, Yang Z, Zhang M e	J Neuroinflammation	2026
Oligodendrocyte transcription factor 2 orchestrates glioblastoma immune evasion [PMID:41591814]	Zhang X, Xue J, Zhao C, Zeng C, Zhong J	J Clin Invest	2026
Indole-3-propionic acid inhibits astrocyte inflammation and promotes motor funct [PMID:41663028]	Yu D, Kang J, Jiang W, Zhang C, Zhao X e	Neuropharmacology	2026
Cobrotoxin mitigates neuroinflammation and cognitive impairment by suppressing C [PMID:41671614]	Li Z, Tan B, Dong K, Yu X, Zhang SW et a	Biochem Pharmacol	2026
Peripheral macrophages and T-cells accumulate in the degenerating optic tract af [PMID:41740873]	Main BS, Villapol S, Buenaventura RG, Ha	Brain Behav Immun	2026
Melanoma cell inoculation improves cognitive impairment in the 5xFAD mouse model [PMID:41760781]	Bruna-Jara B, More J, Lobos P, Ponce DP,	Scientific reports	2026
Chemokine-defined macrophage niches establish spatial organization of tumor immu [PMID:41872505]	Ghosh S, Li X, Rawat K, Dighal A, Kalino	Nat Immunol	2026
Agonists for cytosolic bacterial receptor ALPK1 induce antitumour immunity. [PMID:41372408]	Tian X, Liu J, Li Y, Wang Y, Luo Y, He H	Nature	2026
HTLV1-associated myelopathy as a translational model of progressive neurodegener [PMID:41926707]	da Silva MTT, Araujo AQC	Brain : a journal of neurology	2026
Inflammatory Processes in Alzheimer's Disease-Pathomechanism, Diagnosis and Trea [PMID:37047492]	Unknown	Int J Mol Sci	2023
Pathogenesis of Alzheimer's Disease. [PMID:36613544]	Unknown	Int J Mol Sci	2022
Restoring nuclear entry of Sirtuin 2 in oligodendrocyte progenitor cells promote [PMID:35264567]	["Ma Xiao-Ru", "Zhu Xudong", "Xiao Yujie	Nature communications	2022
Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells. [PMID:31585093]	["Neumann Bj\u00f6rn", "Baror Roey", "Zh	Cell stem cell	2019
Alzheimer's disease. [PMID:31753135]	["Soria Lopez, Jose A", "Gonz\u00e1lez,	Handbook of clinical neurology	2019
Alzheimer's disease. [PMID:28872215]	["Lane, C A", "Hardy, J", "Schott, J M"]	European journal of neurology	2018
Current understanding of Alzheimer's disease diagnosis and treatment. [PMID:30135715]	["Weller, Jason", "Budson, Andrew"]	F1000Research	2018

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning ITE in their description or question text

Loss of AQP4 Polarization Impairs Glymphatic Perivascular Influx, Causing Metabo

Score: 0.690 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The aquaporin-4 (AQP4) water channel represents a critical component of the brain

Time-Limited AQP4 Inhibition for Acute Cytotoxic Edema Followed by Therapeutic R

Score: 0.690 · neurodegeneration · 2026-04-21

## **Molecular Mechanism and Rationale** Aquaporin-4 (AQP4) represents the predominant water channel in the central ner

STMN2 Restoration as a Prerequisite for Axon Growth After TDP-43 Clearance

Score: 0.683 · neurodegeneration · 2026-04-14

**Molecular Mechanism and Rationale** The molecular foundation of STMN2 restoration as a prerequisite for axonal regene

White Matter Oligodendrocyte Protection via CXCL10 Inhibition

Score: 0.675 · neurodegeneration · 2026-04-04

## Molecular Mechanism and Rationale The chemokine CXCL10 (C-X-C motif chemokine ligand 10), also known as interferon-γ

Mitochondrial-Lysosomal Contact Site Engineering

Score: 0.668 · neurodegeneration · 2026-04-02

## Mechanistic Overview Mitochondrial-Lysosomal Contact Site Engineering starts from the claim that modulating RAB7A wit

White Matter Vulnerability Prevention via Oligodendrocyte Protection

Score: 0.667 · neurodegeneration · 2026-04-04

## Mechanistic Overview White Matter Vulnerability Prevention via Oligodendrocyte Protection starts from the claim that

RNA Granule Nucleation Site Modulation

Score: 0.662 · neurodegeneration · 2026-04-02

## Mechanistic Overview RNA Granule Nucleation Site Modulation starts from the claim that modulating G3BP1 within the di

Oligodendrocyte White Matter Vulnerability

Score: 0.651 · neurodegeneration · 2026-04-02

## Mechanistic Overview Oligodendrocyte White Matter Vulnerability starts from the claim that modulating MOG within the

TREM2-Mediated Oligodendrocyte-Microglia Metabolic Coupling in White Matter Neur

Score: 0.649 · neurodegeneration · 2026-04-17

**Molecular Mechanism and Rationale** The TREM2-mediated oligodendrocyte-microglia metabolic coupling pathway represent

CLU-APOE-TREM2 Tripartite Axis as a Coordinate Therapeutic Target

Score: 0.648 · neurodegeneration · 2026-04-14

## Mechanistic Overview CLU-APOE-TREM2 Tripartite Axis as a Coordinate Therapeutic Target starts from the claim that mod

White Matter Immune Checkpoint Restoration

Score: 0.644 · neurodegeneration · 2026-04-04

## Mechanistic Overview White Matter Immune Checkpoint Restoration starts from the claim that modulating CXCL10 within t

Cross-Cell Type Synaptic Rescue via Tripartite Synapse Restoration

Score: 0.620 · neurodegeneration · 2026-04-04

## Mechanistic Overview Cross-Cell Type Synaptic Rescue via Tripartite Synapse Restoration starts from the claim that mo

Neurovascular Permeability Score (NVPS): Composite Plasma + Imaging Biomarker Pa

Score: 0.600 · unknown disease · 2026-04-26

A LASSO-optimized composite score integrating plasma GFAP, S100B, NFL, soluble PDGFR-β, and claudin-5 fragments to achie

TREM2-Mediated Oligodendrocyte-Microglia Cross-talk in White Matter Neurodegener

Score: 0.600 · neurodegeneration · 2026-04-21

## **Molecular Mechanism and Rationale** The TREM2 (Triggering Receptor Expressed on Myeloid cells 2) signaling pathway